GlassScriptPhysician profile
Arturo Balandra
NPI 1982760369
$15,961.66
in general payments reported to CMS, 2019-2025
47 companies · $3,234 in 2025
The $3,234 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,218 · 2020: $620 · 2021: $1,192 · 2022: $1,616 · 2023: $5,311 · 2024: $2,770 · 2025: $3,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,766 · Consulting Fee: $1,090 · Travel and Lodging: $972 · Education: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,766.40 |
| Consulting Fee | $1,090.00 |
| Travel and Lodging | $971.74 |
| Education | $487.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $3,679.95 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Valencia Technologies Corporation | $1,032.73 | 2023 | Ecoin Device Kit |
| Bayer Healthcare Pharmaceuticals INC. | $907.30 | 2021-2025 | |
| Urogen Pharma, INC. | $854.30 | 2021-2025 | Jelmyto |
| Astellas Pharma US INC | $816.92 | 2019-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $739.78 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue, Spaceoar System |
| Axonics, INC. | $727.54 | 2020-2024 | Axonics |
| Endo Pharmaceuticals INC. | $709.14 | 2019-2024 | Xiaflex, Aveed, Edex |
| Sumitomo Pharma America, INC. | $476.21 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $463.24 | 2020-2025 | Speedicath |
| Myriad Genetic Laboratories, INC. | $431.31 | 2021-2024 | Prolaris, Precisetumor |
| Rochester Medical Corporation | $385.92 | 2019-2022 | |
| Teleflex LLC | $370.54 | 2021-2025 | Urolift, Barrigel |
| Pfizer INC. | $348.06 | 2019-2025 | |
| Procept Biorobotics Corporation | $338.87 | 2021-2025 | Aquabeam System, Aquabeam Robotic System |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $325.30 | 2019-2025 | Provenge |
| Blue Earth Diagnostics | $296.03 | 2019-2024 | |
| Olympus America INC. | $289.60 | 2023-2025 | Itind System |
| Bioprotect Medical, INC. | $255.47 | 2025 | Bioprotect Balloon Implant System |
| Janssen Scientific Affairs, LLC | $227.46 | 2025 | Erleada, Akeega, Balversa |
| Novartis Pharmaceuticals Corporation | $212.37 | 2024-2025 | |
| Endo USA, INC. | $211.16 | 2024-2025 | Xiaflex, Aveed, Edex |
| Tolmar Pharmaceuticals, INC. | $203.24 | 2021-2022 | |
| Abbvie INC. | $187.26 | 2022-2025 | Botox |
| Neotract INC. | $167.49 | 2019 | |
| Amgen INC. | $146.90 | 2019 | |
| Laborie Medical Technologies Corp. | $129.88 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Intuitive Surgical, INC. | $128.00 | 2025 | |
| Srs Medical Systems, INC. | $107.69 | 2021-2024 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Antares Pharma, INC. | $91.37 | 2019-2025 | Xyosted |
| Tolmar, INC. | $86.00 | 2023-2025 | Eligard, Jatenzo |
| Verity Pharmaceuticals INC. | $77.78 | 2023-2024 | Trelstar, Tlando |
| C. R. Bard, INC. & Subsidiaries | $55.10 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $53.00 | 2024 | Erleada |
| Ferring Pharmaceuticals INC. | $48.44 | 2024-2025 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $42.29 | 2024 | |
| Bard Access Systems, INC. | $41.88 | 2019 | |
| Urovant Sciences INC | $41.17 | 2022 | |
| Allergan, INC. | $39.40 | 2019-2022 | |
| Foundation Medicine, INC. | $38.78 | 2023 | |
| Baudax Bio INC. | $37.80 | 2021 | |
| Bluewind Medical | $28.98 | 2025 | |
| Telix Pharmaceuticals | $24.37 | 2023 | Illuccix |
| Davol INC. | $24.20 | 2025 | Arista |
| Merck Sharp & Dohme LLC | $23.86 | 2023 | Keytruda, Lynparza |
| Halozyme INC | $19.82 | 2023 | |
| Ambu INC. | $17.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arturo Balandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.